D. Hughes

发表

O231: Long‐term persistence of patient‐derived hepatitis B virus infection in 3D microfluidic primary hepatocyte cultures

D. Burger, M. Thursz, E. Large, 2014 .

Scalable and Resilient SARS-CoV2 testing in an Academic Centre

M. Jamal-Hanjani, S. Gamblin, M. Hubank, 2020, medRxiv.

Erythrocyte aggregation and metabolic syndrome.

P. Tinley, R. Richards, P. Gyawali, 2014, Clinical hemorheology and microcirculation.

Fluvastatin Inhibits Hepatitis C Replication in Humans

C. Aston, M. Hasan, J. Fazili, 2008, The American Journal of Gastroenterology.

Severe Hyperbilirubinemia as a Side Effect of Three-Week Treatment with Glecaprevir/Pibrentasvir Resulting in Sustained Virologic Response

T. Syed, M. Hayat, J. Fazili, 2020 .

Measurement and evaluation of biomarkers of oxidative stress, inflammation, haemorheology and whole blood antioxidant capacity in healthy, rheumatoid arthritis and Parkinson’s disease populations

D. Hughes, 2018 .

3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection

R. Fleck, M. Thursz, A. M. Ortega-Prieto, 2018, Nature Communications.

Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes

F. Dutheil, D. Wundersitz, A. Benson, 2020, Seminars in Thrombosis and Hemostasis.

Using chemiluminescence to determine whole blood antioxidant capacity in rheumatoid arthritis and Parkinson's disease patients.

R. Richards, L. Lexis, D. Hughes, 2018, Luminescence : the journal of biological and chemical luminescence.

Diverse Human Immunodeficiency Virus–1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings

R. Gross, J. Ritz, B. Grinsztejn, 2020 .

3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection

R. Fleck, M. Thursz, A. M. Ortega-Prieto, 2018, Nature Communications.